>
>
Influenza Vaccines Market – By Vaccine Type (Inactivated, Live Attenuated), Indication (Quadrivalent, Trivalent), Technology (Egg-based, Cell-based), Flu Type (Seasonal, Pandemic), Age Group, Route of Administration, End-user, Global Forecast 2024 – 2032
Download Free PDF

Influenza Vaccines Market
Get a free sample of this reportGet a free sample of this report Influenza Vaccines Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 10
Tables & Figures: 449
Countries covered: 19
Pages: 240
Download Free PDF
Influenza Vaccines Market Size
Influenza Vaccines Market size was valued to be worth USD 7.1 billion in 2023 and is estimated to witness 6.8% CAGR from 2024 to 2032. The increasing prevalence of influenza, rising government health initiatives & immunization programs, and growing advancements in vaccine technology are the major factors responsible for the growth of this market.
For instance, during the 2021-2022 season, the Centers for Disease Control and Prevention reported a significant burden of influenza in the U.S., with an estimated 9.4 million flu cases. Among those, 4.3 million medical facility visits related to flu, 100,000 flu-related hospitalizations, and 4,900 flu-related deaths. This surge in influenza cases contributes to an increased demand for influenza vaccines, thereby fostering the market expansion.
Influenza vaccines, commonly known as flu vaccines, are preventive measures designed to protect individuals against influenza viruses. Influenza is a highly contagious respiratory illness caused by influenza viruses, and it can lead to severe illness or complications, especially in vulnerable populations such as the elderly and young children. The primary purpose of influenza vaccines is to stimulate the immune system to recognize and mount a defense against the influenza virus. These vaccines typically contain inactivated (killed) viruses, live attenuated (weakened) viruses.
Influenza Vaccines Market Trends
However, the high cost associated with vaccine development and longer vaccine production timelines may hamper the industry landscape.
Influenza Vaccines Market Analysis
Based on vaccine type, the global market is segmented into inactivated and live attenuated. The inactivated segment is projected to experience growth at 6.9% over the coming years.
Based on indication, the global influenza vaccines market is classified as quadrivalent and trivalent. The quadrivalent segment was valued at USD 6.2 billion 2023.
Based on technology, the global influenza vaccines market is categorized into egg-based and cell-based. The egg-based segment is anticipated to reach USD 10.8 billion by 2032.
Based on flu type, the global influenza vaccines market is divided into seasonal and pandemic. The seasonal segment accounted for largest business share of 72.4% in 2023.
Based on age group, the influenza vaccines market is bifurcated into adults and pediatrics. The adult segment is estimated to be valued at USD 10.5 billion by 2032 with CAGR of 7.3%.
Based on route of administration, the global influenza vaccines market is segmented into injection and nasal spray. The injection segment dominated the market in 2023 and is expected to show similar trend during the analysis period.
Based on end-user, the global influenza vaccines market is divided into hospitals, clinics, and other end-users. The hospitals segment accounted for highest revenue share of 72.8%.
The North America influenza vaccines market is anticipated to grow at CAGR 6.5% and is expected to dominate the market throughout the forthcoming years.
Influenza Vaccines Market Share
The influenza vaccines industry is characterized by the active participation of key pharmaceutical companies and biotech firms striving to address the public health challenges posed by seasonal and pandemic influenza. Leading players such as Sanofi, GlaxoSmithKline (GSK), CSL Limited have established themselves as major contributors to the market, offering a range of trivalent and quadrivalent influenza vaccines. The market continues to evolve, the competitive landscape is likely to be shaped by ongoing advancements, regulatory considerations, and responses to emerging infectious threats.
Influenza Vaccines Market Companies
Key leaders operating in the influenza vaccines industry are as mentioned below:
Influenza Vaccines Industry News:
The influenza vaccines market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Vaccine Type
Market, By Indication
Market, By Technology
Market, By Flu Type
Market, By Age Group
Market, By Route of Administration
Market, By End-user
The above information is provided for the following regions and countries: